Corvex, formerly Movano, announced July 1, 2026 that it disposed of Movano’s Wellness/Medical Ring assets to a lender and completed conversions of Series C and D preferred stock. The company elected three new directors to refresh governance. Chance Moreland was named CFO and Seth Demsey co-CEO, signaling stronger governance and a sharpened AI infrastructure focus.
Material dilution from automatic conversion of Series C/D and larger share-count increase could pressure near-term valuation and stock price, despite positive governance and strategic shift.
Near-term dilution from Series C/D conversions may weigh on MOVE, but governance upgrades and AI execution could drive upside in 12–24 months.
Category fits Corporate Developments: governance changes, capital-structure actions, and strategic pivot milestones.